CNS Breathe Right Sales, FiberChoice Cuts Produce "Return To Profitability"
This article was originally published in The Tan Sheet
Executive Summary
CNS expects FiberChoice to become a $30 mil. product in the long term, which would equate to about 10% of the fiber category, the company said.
You may also be interested in...
CNS International Growth, Ad/Promo Cuts Key Strategies For FY 2003
CNS aims to increase international sales by up to 20% in 2002 as part of its strategy to boost revenue and continue recent earnings gains
CNS Restructuring Plan Focused On Bolstering Breathe Right Sales
CNS recorded a $1.2 mil. charge against earnings in the second quarter as part of a restructuring plan aimed at strengthening its core Breathe Right nasal strip business and returning the firm to sustainable profitability.
Breathe Right Children's Products Provide "Drug-Free" Cold Remedy
CNS' two new children's Breathe Right nasal strips, now reaching food, drug and mass outlets nationwide, offer a new solution for the "winter woes of a stuffy nose," according to the company.